GenCure Opens BioManufacturing Center for Large-Scale Production of Adult Stem Cells to Support Development of New Cellular Therapies

GenCure, a subsidiary of BioBridge Global, today opened the first phase of a new biomanufacturing center designed to address a critical roadblock slowing the advancement of cellular therapies and the field of regenerative medicine: A lack of access to large-scale stem cell manufacturing and support services required for cGMP (Current Good Manufacturing Process)-compliant production of […]

Read More